Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-12

Clinical Trial Update: Evaluation of Lysine-Specific Demethylase 1 [NA]

View source ↗

Summary

A clinical trial evaluating Lysine-Specific Demethylase 1 for hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypertension | NA | Status: WITHDRAWN